close
MENU
Hot Topic EARNINGS
Hot Topic EARNINGS
Chief reporter
Chief reporter

Will Mace

Will Mace began his journey in business journalism at The Independent weekly business paper in Auckland around 2009, and then moved on to become a founding reporter for the Fairfax Business Bureau, which supplied news to the Stuff.co.nz website, The Dominion Post, The Press, and other regional Fairfax mastheads.

Having shifted to London in 2013, he spent six years at Acuris Global (aka Mergermarket/Dealreporter) covering public company mergers and acquisitions and event-driven special situations across Europe for an investment banking and hedge fund audience. In 2016 he was tasked with launching an entirely new Acuris service called Activistmonitor, and became an authority on the subject of shareholder activism as it grew in the region.

Over his final two years in London, Will juggled editorship and reporting across activism, M&A, ECM, and regulatory/competition review coverage. He joined NBR in April 2021 and was promoted to chief reporter in May 2025.

He enjoys live music, sailing, skiing, answering his toddler’s ‘Why?’ questions, and critiquing rugby from the safety of the sidelines. 

Will Mace's Articles

Allbirds shares leap on Nasdaq debut

Read Article
Thu, 04 Nov 2021

Aussie liquidator prevented from managing Decmil subbies retention fund

Read Article
Wed, 03 Nov 2021

Hiringa breaks ground on $50m green hydrogen refuelling network

Read Article
Tue, 02 Nov 2021

Catalist to bring first SME IPO to market next week

Read Article
Tue, 02 Nov 2021

Grocery companies resist calls for separation, divestment

Read Article
Mon, 01 Nov 2021

FOMO for investors, trading platforms could skew markets

Read Article
Mon, 01 Nov 2021

Air NZ to dip further into Crown loan facility

Read Article
Thu, 28 Oct 2021

Chorus chair says wireless broadband 'slowest when you most need it'

Read Article
Wed, 27 Oct 2021

Move Logistics launches $40m capital raise

Read Article
Wed, 27 Oct 2021

Grocery ombudsman could solve supplier-retailer issues ‘overnight’

Read Article
Tue, 26 Oct 2021

Equities ‘pretty choppy’ as interest rate rises balance earnings hits

Read Article
Mon, 25 Oct 2021

Clinical trial companies merge under Pencarrow majority ownership

Read Article
Fri, 22 Oct 2021
1 99 100 101 102 103 117